Morgan Stanley’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.5M | Buy |
|
|||||
|
2025
Q1 | $9.38M | Buy |
|
|||||
|
2024
Q4 | $2.86M | Buy |
|
|||||
|
2024
Q3 | $5.94M | Buy |
|
|||||
|
2024
Q2 | $2.3M | Sell |
|
|||||
|
2024
Q1 | $14.3M | Sell |
|
|||||
|
2023
Q4 | $25.8M | Buy |
|
|||||
|
2023
Q3 | $1.45M | Buy |
|
|||||
|
2023
Q2 | $1.46M | Sell |
|
|||||
|
2023
Q1 | $2.15M | Buy |
|
|||||
|
2022
Q4 | $2.97M | Sell |
|
|||||
|
2022
Q3 | $2.74M | Sell |
|
|||||
|
2022
Q2 | $2.98M | Buy |
|
|||||
|
2022
Q1 | $2.6M | Buy |
|
|||||
|
2021
Q4 | $2.53M | Buy |
|
|||||
|
2021
Q3 | $1.95M | Sell |
|
|||||
|
2021
Q2 | $4.19M | Buy |
|
|||||
|
2021
Q1 | $3.44M | Buy |
|
|||||
|
2020
Q4 | $463K | Buy |
|
|||||
|
2020
Q3 | $109K | Sell |
|
|||||
|
2020
Q2 | $434K | Sell |
|
|||||
|
2020
Q1 | $7.12M | Sell |
|
|||||
|
2019
Q4 | $17M | Buy |
|
|||||
|
2019
Q3 | $7.17M | Buy |
|
|||||
|
2019
Q2 | $670K | Buy |
|
|||||
|
2019
Q1 | $809K | Sell |
|
|||||
|
2018
Q4 | $9.92M | Buy |
|
|||||
|
2018
Q3 | $3.38M | Sell |
|
|||||
|
2018
Q2 | $2.92M | Buy |
|
|||||
|
2018
Q1 | $3.91M | Sell |
|
|||||
|
2017
Q4 | $32.6M | Buy |
|
|||||
|
2017
Q3 | $546K | Buy |
|
|||||
|
2017
Q2 | $121K | Sell |
|
|||||
|
2017
Q1 | $310K | Buy |
|